Luana G Sousa
Overview
Explore the profile of Luana G Sousa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamidi S, Dadu R, Zafereo M, Ferrarotto R, Wang J, Maniakas A, et al.
JAMA Oncol
. 2024 Jul;
10(9):1264-1271.
PMID: 38990526
Importance: BRAF/MEK inhibitors revolutionized the treatment of BRAF V600E-variant anaplastic thyroid carcinoma (BRAFv-ATC), offering improved outcomes for patients with this previously incurable disease. Observations: Anaplastic thyroid carcinoma (ATC) accounts for...
2.
Dal Lago E, Sousa L, Yang Z, Hoff C, Bonini F, Sawyer M, et al.
Oral Oncol
. 2024 Mar;
151:106759.
PMID: 38507991
Objectives: Lung metastases in adenoid cystic carcinoma (ACC) usually have indolent growth and the optimal timing to start systemic therapy is not established. We assessed ACC lung metastasis tumor growth...
3.
Ferrarotto R, Sousa L, Feng L, Mott F, Blumenschein G, Altan M, et al.
J Clin Oncol
. 2023 Mar;
41(15):2843-2851.
PMID: 36898078
Purpose: We conducted a phase II trial evaluating the efficacy of VEGFR inhibitor axitinib and PD-L1 inhibitor avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC). Patients And Methods:...
4.
Lazar Neto F, Sousa L, Lewis W, Glisson B, Heymach J, Tsao A, et al.
J Intensive Care Med
. 2021 Nov;
37(8):1055-1059.
PMID: 34787022
Targeted therapy and immune checkpoint inhibitors (ICI) have drastically improved outcomes of metastatic non-small cell lung cancer (NSCLC) patients in outpatient settings. Because trials on critically ill patients are improbable,...
5.
Sousa L, Wang K, Torman D, Binks B, Rubin M, Andersen C, et al.
Cancer
. 2021 Oct;
128(3):509-518.
PMID: 34661906
Background: Salivary duct carcinoma (SDC) and adenocarcinoma, not otherwise specified (adeno-NOS), are rare salivary gland cancers. Data on the efficacy of systemic therapy for these diseases are limited. Methods: Data...
6.
Ferrarotto R, Sousa L, Qing Y, Kaya D, Stephen B, Jain D, et al.
Adv Ther
. 2021 Jul;
38(8):4581-4591.
PMID: 34241781
Introduction: Patients with advanced cutaneous squamous cell carcinoma (CSCC) have a poor prognosis. Blocking the PD-1-PD-L1 axis has shown promising activity in this patient population. We assessed the safety and...